Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.06 – $0.57
4% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8M | $4.1M | $4.1M | $7.2M | $13.0M | $11.8M | $5.0M | $4.4M |
| Cost of revenue | $2.7K | $63.3K | $82.5K | $2.0M | $2.4M | $2.2M | $5.8M | $0 |
| Gross profit | $1.8M | $4.1M | $4.1M | $5.3M | $10.6M | $9.6M | $5.0M | $4.4M |
| Gross margin | 99.8% | 98.5% | 98.0% | 72.9% | 81.4% | 81.3% | 100.0% | 100.0% |
| R&D | $4.1M | $7.6M | $9.4M | $15.4M | $36.6M | $30.9M | $86.9M | $46.7M |
| Operating income | −$5.8M | −$12.4M | −$10.8M | −$18.5M | −$37.9M | −$39.8M | −$153.7M | −$70.9M |
| EBITDA | −$5.8M | −$7.7M | −$14.6M | −$23.7M | −$35.3M | −$47.4M | −$148.0M | −$67.4M |
| Net income | −$3.9M | −$7.8M | −$10.5M | −$18.5M | −$37.9M | −$37.9M | −$149.7M | −$69.0M |
| Net margin | -213.7% | -188.4% | -254.2% | -255.2% | -292.0% | -321.9% | -3011.7% | -1569.8% |
| EPS (diluted) | -0.05 | -0.07 | -0.09 | -0.13 | -0.23 | -0.21 | -0.72 | -0.32 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2M | $-0.12 | $-0.12–$-0.12 | 1 |
| 2027 | $2M | $-0.08 | $-0.08–$-0.08 | 1 |
| 2028 | $17M | $-0.04 | $-0.04–$-0.04 | 1 |
| 2029 | $970M | $1.70 | $1.70–$1.70 | 1 |
Forward consensus · source: Financial Modeling Prep
IMUGENE LTD
No one on the platform currently holds IUGNF.
No tracked institution reports a position in IUGNF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-07-02 | 1-for-34reverse |
| 2015-10-28 | 17-for-15 |
No one on the platform has traded IUGNF yet.
| $160M |
| — |
| MSCLFSatellos Bioscience Inc. | $6.25 | +11.81% | $97M | — |
| NICXFNicox S.A. | $0.30 | +0.00% | $31M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.5× sales vs its 69.8× historical median P/S.
Fair value ≈ $11.29 · price $0.08 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$IUGNF I used AI to create this meme that pretty much explains Paul, Leslie, and the whole company.
View on StockTwits ↗$IUGNF share purchase plan only for those in Australia & New Zealand!! A little unfair. 👊🏼
View on StockTwits ↗$IUGNF wheres this going. I really think company is running out of money. They talk a good game. But have nothing to show at this point.
View on StockTwits ↗$IUGNF this will keep splitting and investors will keep losing . I hate this
View on StockTwits ↗$IUGNF lets move this sp. Company is taking action to help.
View on StockTwits ↗$IUGNF as company said in there shareholder letter. They cant control stock price. But understand that investors are worried. Maybe bringing shares down will help . I dont know. i would end upp with 588 shares if split today. Would be better to wait with good news on the horizon.
View on StockTwits ↗$IUGNF whatever it takes move to nasdaq knowing that excellent phase results are in the mix. Screw this 1 for 34 split.
View on StockTwits ↗$IUGNF letter to shareholders put out on april 30th. ASX announcement on website
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.